Over 127 mn coronavirus vaccine doses administered so far: Health Ministry

India has administered more than 127 mn coronavirus vaccine doses to eligible beneficiaries till Monday evening, the Union Health Ministry said

Coronavirus, vaccine, covid-19, tests
Press Trust of India New Delhi
2 min read Last Updated : Apr 20 2021 | 6:33 AM IST

India has administered more than 12.69 crore coronavirus vaccine doses to eligible beneficiaries till Monday evening, the Union Health Ministry said.

Total 73,600 COVID-19 Vaccination Centres (CVCs) were operational on Monday, the highest so far, it said, adding that on an average 45,000 CVCs were functional on any given day earlier.

Workplace vaccinations have also enabled such a high turnout of beneficiaries, the ministry said in a statement.

The cumulative number of COVID19 vaccine doses administered in the country stands at 12,69,56,032, according to a provisional report till 8 pm on Monday.

The beneficiaries include 91,69,353 healthcare workers (HCWs) who have taken the first dose and 57,66,012 HCWs who have taken the second dose, 1,14,21,780 frontline workers (FLWs) who have received the first dose and56,64,213 FLWs who have taken the second dose.

On the 94th day of the nationwide COVID-19 vaccination drive on Monday, a total of 31,03,474 vaccine doses were given till 8 pm -- 21,67,374 beneficiaries were vaccinated for the first dose and 9,36,100 for the second dose.

Phase-I of the nationwide COVID-19 vaccination drive was launched on January 16, prioritizing protection for healthcare workers and frontline workers.

The phase-II was initiated from March 1, focusing on protecting most vulnerable i.e. all people above 45 years of age.

Everyone above 18 years of age will be eligible to get vaccinated against COVID-19 from May 1, the central government said on Monday as it liberalised the vaccination drive to allow states, private hospitals and industrial establishments to procure the doses directly from manufacturers.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Apr 20 2021 | 6:25 AM IST

Next Story